Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Wegovy 2.4 mg produced 14.9% at the same timepoint
A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result
Some patients also research metabolic alternatives, such as 5-Amino-1MQ vs Semaglutide, to see which mechanism fits their goals best
Lilly has already filed regulatory applications in the United States, the EU and several other countries seeking approval for orforglipron in obesity
US$ 25.48
US$ 25.32
US$ 20.21
US$ 28.47
US$ 20.54
US$ 29.34
US$ 23.37
US$ 27.37
